Skip to main content
OpenTrials

Clinical trial condition

Mesothelioma, Malignant

Explore clinical trials studying Mesothelioma, Malignant. Study availability and eligibility vary by location and protocol.

225 public trials 44 recruiting studies
Refine in advanced search Browse all conditions

Mesothelioma, Malignant trial results

Completed

Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma

NCT00101283

Conditions
Adenoma, Lung Diseases, Lung Neoplasms, +11 more
Locations
  • Eastern Connecticut Hematology and Oncology Associates Norwich, Connecticut, United States
  • Tunnell Cancer Center at Beebe Medical Center Lewes, Delaware, United States
  • CCOP - Christiana Care Health Services Newark, Delaware, United States
  • Mayo Clinic - Jacksonville Jacksonville, Florida, United States
View all 115 locations
View Trial Details
Completed

First-in-human Study of BAY2287411 Injection, a Thorium-227 Labeled Antibody-chelator Conjugate, in Patients With Tumors Known to Express Mesothelin

NCT03507452

Conditions
Adenoma, Advanced Pancreatic Ductal Adenocarcinoma (Optional, Dose Expansion, Not Initiated), Advanced Recurrent Malignant Peritoneal Epithelioid Mesothelioma, +15 more
Locations
  • National Cancer Institute - Maryland Bethesda, Maryland, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • HUS, Meilahden sairaala Helsinki, Finland
  • Nederlands Kanker Instituut Amsterdam, Netherlands
View Trial Details
Completed

An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma

NCT00738582

Conditions
Adenoma, Lung Diseases, Lung Neoplasms, +12 more
Locations
  • University of Alabama, Birmingham Birmingham, Alabama, United States
  • University of California, San Diego La Jolla, California, United States
  • UCLA Medical Hematology & Oncology Los Angeles, California, United States
  • University of California, San Francisco San Francisco, California, United States
View all 28 locations
View Trial Details

Related conditions